Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Cigna Corp.

Even As PBMs Face Reckoning, Formulary Exclusions Rise Again In 2023

Congressional scrutiny aside, ‘the rebate model remains alive and well’ as the big three pharmacy benefit managers exclude around 600 drugs each from their formularies.

Commercial Pricing Debate

AHIP, PhRMA Try to Control Narrative as Heat on PBMs Intensifies

As health insurance lobby launches advertising campaign to defend ‘evidence-based, market-driven tools,’ drug firms point out the connection between insurers and pharmacy benefit managers.

Legislation Pricing Debate

Express Scripts Unveils New Co-Pay Cap For Generics Amid PBM Scrutiny

Cigna’s PBM, Express Scripts, is looking to “further align incentives across the pharmaceutical supply chain, consumers, and clients,” with a trio of new products available starting this summer.

Reimbursement Pricing Debate

Obesity Drug Coverage Should Not Be Required For ACA Plans, Cigna Tells CMS

Insurer's concerns about the cost of covering drugs that could be used by large swaths of the population has contributed to their reluctance to pay for them, but in comments to the agency, drug firms, consumer advocates and medical professionals urged the Centers for Medicare and Medicaid Services to promote coverage in the commercial plans governed by the Affordable Care Act.

Reimbursement Market Access
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services